Before The Freeze: US FDA Inspection Data Pointed To Continued Foreign Facility Focus

 
• By Derrick Gingery

Until the coronavirus forced it to stop, the FDA had planned to up domestic and foreign inspections in FY 2020 and FY 2021, as the longer-term trend showed domestic inspections dropping and foreign inspections rising.

Pill Production
The FDA expects to increase domestic and foreign facility Good Manufacturing Practice inspections substantially in FY 2020 and FY 2021, compared to FY 2019. • Source: Shutterstock

More from Manufacturing

More from Compliance